Balanced news tone
News Sentiment
JUBLPHARMA sentiment intelligence
Jubilant Pharmova Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
88/100 classification confidence.
directly relevant articles
high-authority source matches
-0.5% over one week, -1.3% over four weeks, trend inactive, and near fair-value range.
Stock Alert: Infosys, Vedanta, LIC, Embassy Developments, Jubilant Pharmova
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Stock Alert: Infosys, Vedanta, LIC, Embassy Developments, Jubilant Pharmova
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Business Standard
Jubilant Pharmova re-appoints MDs for three years
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- scanx.trade
Jubilant Pharmova Announces FY26 Earnings Webinar on May 22, 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 May 2026 07:00
- Source
- scanx.trade
Trade Spotlight: How should you trade Jubilant Pharmova, Linde India, Emcure Pharma, Granules, Ather...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Mar 2026 07:00
- Source
- Moneycontrol.com
Stocks to Watch Today: Fractal Analytics, AYE, Manappuram, Alkem Labs, Zydus Life, Jubilant Pharmova,...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Feb 2026 08:00
- Source
- Moneycontrol.com
Jubilant Pharmova shares drop nearly 5% after net profit slumps 45% in December quarter
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 09 Feb 2026 08:00
- Source
- Upstox
Jubilant Pharmova shares fall over 4% after Q3 net profit declines 17% YoY
- Tone
- Negative 22/100
- Event
- Earnings
- Published
- 06 Feb 2026 08:00
- Source
- Business Standard
Are Jubilant Pharmova Limited's (NSE:JUBLPHARMA) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- simplywall.st
Jubilant Pharmova to Acquire API Business from Jubilant Biosys for ₹595.59 Crore
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Oct 2025 07:00
- Source
- scanx.trade
Jubilant Pharmova Limited's (NSE:JUBLPHARMA) top owners are private companies with 50% stake, while 22% is held by institutions
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 18 Sep 2025 07:00
- Source
- simplywall.st
Jubilant Pharmova's Roorkee Facility Completes USFDA Pre-Approval Inspection with 4 Observations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Aug 2025 07:00
- Source
- scanx.trade
Jubilant Pharmova Q1 Profit Plunges 79% Despite Revenue
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 29 Jul 2025 07:00
- Source
- HDFC Sky
Sunil Singhania-owned Abakkus trims stakes in Jubilant Pharmova, Ion Exchange: Check the top ten holdings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jul 2025 07:00
- Source
- Moneycontrol.com
Why is Jubilant Pharmova share price buzzing in an overall weak market?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 13 Jun 2025 07:00
- Source
- Business Standard
Jubilant Group promoters to offload stakes in listed companies via block deals: Report
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2025 07:00
- Source
- The Economic Times
Jubilant Group's promoter likely to offload small stakes in listed firms, including 2% in Jubilant Food,...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2025 07:00
- Source
- Moneycontrol.com
Jubilant Pharmova shares up 3% after arm's US facility receives EIR with VAI status from USFDA; all you need to know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Mar 2025 07:00
- Source
- Upstox
Jubilant Pharmova Ltd. Share Price Today - Jubilant Pharmova Ltd. Stock Price Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jan 2025 02:04
- Source
- CNBC TV18
Jubilant Pharmova subsidiary gets VAI classification for Washington unit from USFDA, stock hits 52-week high
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Sep 2024 07:00
- Source
- Upstox
Jubilant Pharmova Ltd. Share Price Today | Jubilant Pharmova Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Mar 2022 19:02
- Source
- Value Research
Jubilant Pharmova Share Price Today - Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jan 2022 23:09
- Source
- ICICI Direct
Jubilant Pharmova Share Price - Live NSE: JUBLPHARMA Stock Price & Chart
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Oct 2021 04:52
- Source
- Upstox